Back

Contextualising ATTR-CM clinical trial designs

29 August 2026 (12:50 - 13:05)
Organised by: Logo
Congress Presentation Part of: In focus: the next era of transthyretin amyloid cardiomyopathy (ATTR-CM) management European Society of Cardiology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introductions
Professor S. Solomon (Boston, US)
Presentation thumbnail
Expert perspectives on the evolving ATTR-CM landscape
Professor R. Witteles (Stanford, US)
Presentation thumbnail
Evidence-based ATTR-CM care in practice
Professor O. Azevedo (Guimaraes, PT)
Presentation thumbnail
Q&A and closing
Professor S. Solomon (Boston, US)

Access the full session

Session thumbnail
In focus: the next era of transthyretin amyloid cardiomyopathy (ATTR-CM) management

The Event

Event poster

ESC Congress 2026

29 August 2026 12:50 CET
You may be interested in
thumbnail
Congress Presentation
CARDIO-TTRansform trial in ATTR-CM: design and baseline characteristics
9 May 2026
thumbnail
Congress Presentation
Chatbot prototype for informal carers: a comparison of contextualised and non-contextualised large language model responses
14 June 2025
thumbnail
Congress Presentation
The clinical significance of transthyretin gene variant homozygosity in variant ATTR-CM
26 August 2023
thumbnail
Congress Presentation
Understanding the impact of ATTR-CM
11 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources